Gene · 701
Papers3,969
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
761 to 780 of 3,969
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| SIRT1 regulates mitotic catastrophe via autophagy and BubR1 signaling. | Mol Cell Biochem | 2022 | 35639235 | PubTator, text mining | PubMed |
| BUB3, beyond the Simple Role of Partner. | Pharmaceutics | 2022 | 35631670 | PubTator, text mining | PubMed |
| Construction of a ceRNA Network and Comprehensive Analysis of lncRNA in Hepatocellular Carcinoma. | Genes (Basel) | 2022 | 35627170 | PubTator, text mining | PubMed |
| Diclofenac: A Nonsteroidal Anti-Inflammatory Drug Inducing Cancer Cell Death by Inhibiting Microtubule Polymerization and Autophagy Flux. | Antioxidants (Basel) | 2022 | 35624874 | PubTator, text mining | PubMed |
| The bioinformatics and experimental analysis of the novel roles of virus infection-associated gene CDC20 for prognosis and immune infiltration in hepatocellular carcinoma. | Aging (Albany NY) | 2022 | 35622386 | PubTator, text mining | PubMed |
| Genetic changes associated with relapse in favorable histology Wilms tumor: A Children's Oncology Group AREN03B2 study. | Cell Rep Med | 2022 | 35617957 | PubTator, text mining | PubMed |
| Integrated bioinformatics and statistical approaches to explore molecular biomarkers for breast cancer diagnosis, prognosis and therapies. | PLoS One | 2022 | 35617355 | PubTator, text mining | PubMed |
| The TRiCky Business of Protein Folding in Health and Disease. | Front Cell Dev Biol | 2022 | 35602608 | PubTator, text mining | PubMed |
| Pediatric T-ALL type-1 and type-2 relapses develop along distinct pathways of clonal evolution. | Leukemia | 2022 | 35585141 | PubTator, text mining | PubMed |
| Integrated Analysis of Transcriptome Data Revealed AURKA and KIF20A as Critical Genes in Medulloblastoma Progression. | Front Oncol | 2022 | 35574421 | PubTator, text mining | PubMed |
| High-dose metformin induces a low-glucose dependent genotoxic stress. | Food Chem Toxicol | 2022 | 35568294 | PubTator, text mining | PubMed |
| Polar Chromosomes-Challenges of a Risky Path. | Cells | 2022 | 35563837 | PubTator, text mining | PubMed |
| Cullin 3 Exon 9 Deletion in Familial Hyperkalemic Hypertension Impairs Cullin3-Ring-E3 Ligase (CRL3) Dynamic Regulation and Cycling. | Int J Mol Sci | 2022 | 35563538 | PubTator, text mining | PubMed |
| Identification of HGD and GSTZ1 as Biomarkers Involved Metabolic Reprogramming in Kidney Renal Clear Cell Carcinoma. | Int J Mol Sci | 2022 | 35562974 | PubTator, text mining | PubMed |
| Trovafloxacin drives inflammation-associated drug-induced adverse hepatic reaction by changing macrophage polarization. | Toxicol In Vitro | 2022 | 35537566 | PubTator, text mining | PubMed |
| In Silico Identification of Hub Genes as Observing Biomarkers for Gastric Cancer Metastasis. | Evid Based Complement Alternat Med | 2022 | 35535159 | PubTator, text mining | PubMed |
| Considerations for studying phosphorylation of the mitotic checkpoint pseudokinase BUBR1. | Methods Enzymol | 2022 | 35525552 | PubTator, text mining | PubMed |
| Network Pharmacology and Comparative Transcriptome Reveals Biotargets and Mechanisms of Curcumol Treating Lung Adenocarcinoma Patients With COVID-19. | Front Nutr | 2022 | 35520289 | PubTator, text mining | PubMed |
| Aberrant Expression of BUB1B Contributes to the Progression of Thyroid Carcinoma and Predicts Poor Outcomes for Patients. | J Cancer | 2022 | 35517426 | PubTator, text mining | PubMed |
| Differentially Expressed Genes in Nasopharyngeal Carcinoma Tissues and Their Correlation with Recurrence and Metastasis of Nasopharyngeal Carcinoma. | Comput Math Methods Med | 2022 | 35509856 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/701/papers?page=39